Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prophylactic Antimalarial Activity of DB289 in Volunteers

This study has been completed.
Sponsor:
Information provided by:
Immtech Pharmaceuticals, Inc
ClinicalTrials.gov Identifier:
NCT00408369
First received: December 4, 2006
Last updated: January 25, 2008
Last verified: January 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2007
  Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)